| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,423 | 9,706 | 39,704 | 36,920 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 27,423 | 9,706 | 39,704 | 36,920 | | | Operating Expenses | | Research Development | 13,444 | 13,507 | 16,521 | 20,132 | | Selling General and Administrative | 7,197 | 5,655 | 6,120 | 5,161 | | Non Recurring | 2 | 312 | 3,289 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,780 | (9,768) | 13,774 | 11,627 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,533) | 1,142 | 33 | 14 | | Earnings Before Interest And Taxes | 3,247 | (8,626) | 13,807 | 11,641 | | Interest Expense | 1,339 | 1,671 | 1,768 | 2,042 | | Income Before Tax | 1,908 | (10,297) | 12,039 | 9,599 | | Income Tax Expense | 370 | (87) | 5,800 | (383) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,107) | (10,210) | 6,239 | 9,982 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,538 | (10,210) | 6,239 | 9,982 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,538 | ($10,210) | $6,239 | $9,982 |
|
0.51% Nasdaq 
0.01 (1.45%) 
Income Statement
